mtDNA damage levels as a pharmacodynamic biomarker of CU-13001 efficacy in the Line61 model of PD
Research Grant
Administered By
Neurology, Translational Brain Sciences
Awarded By
Acurex Biosciences Corporation
Start Date
December 1, 2025
End Date
May 30, 2026
Administered By
Neurology, Translational Brain Sciences
Awarded By
Acurex Biosciences Corporation
Start Date
December 1, 2025
End Date
May 30, 2026